Excellerant, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EXCL research report →
About the company
Excellerant, Inc. is an emerging firm that offers diverse health-related consultation and travel coordination services to both corporate clients and private individuals. Its planned offerings encompass advisory services covering conventional and complementary medical practices, alongside advanced medical technologies.
- CEO
- Roman Kopinski
- IPO
- 2021
- Employees
- 1
- HQ
- Brussels, BE
Price Chart
- Market Cap
- $1.13K
- P/E
- -0.03
- P/S
- 0.00
- P/B
- -0.06
- EV/EBITDA
- 0.50
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 106.26%
- ROIC
- 231.85%
- Revenue
- $0 · 0.00%
- Net Income
- $-13,800 · 36.82%
- EPS
- $-0.01 · -63.83%
- Op Income
- $-13,800
- FCF YoY
- -141.77%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -7.25
- Avg Volume
- 8.276
Get TickerSpark's AI analysis on EXCL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our EXCL coverage
Recent articles, reports, and earnings notes.
No research on EXCL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EXCL report →Similar companies
Peers in the same neighborhood.